Jan Schmidt
Do Pharmaceutical Mergers Harm Drug Innovation?
Buch
Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, po…
Mehr
Beschreibung
Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation.Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.
CHF 35.90
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
- ISBN: 978-3-656-96217-5
- EAN: 9783656962175
- Produktnummer: 18320390
- Verlag: GRIN Publishing
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 56 S.
- Masse: H21.1 cm x B14.9 cm x D0.7 cm 94 g
- Auflage: 1. Auflage
- Gewicht: 94
100 weitere Werke von Jan Schmidt:
Ebook (EPUB Format)
CHF 9.00
Ebook (EPUB Format)
CHF 12.00
Ebook (PDF Format)
CHF 15.45
Ebook (EPUB Format)
CHF 11.00
Ebook (PDF Format)
CHF 39.00
Ebook (PDF Format)
CHF 14.20
Ebook (PDF Format)
CHF 14.00
Ebook (PDF Format)
CHF 42.00
Ebook (PDF Format)
CHF 16.75
Ebook (PDF Format)
CHF 172.80
Ebook (PDF Format)
CHF 106.50
Ebook (PDF Format)
CHF 250.20
Ebook (PDF Format)
CHF 13.00
Ebook (EPUB Format)
CHF 5.00
Ebook (PDF Format)
CHF 3.00
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.